Table 1. Characteristics of men and women in the statewide cohort.

		Men (n = 198)	Women (n = 27)	Men vs. Women
AIDS Age (years)		Mean = 39.1 SD = 8.8 Median = 37.9	Mean = 40.0 SD = 11.8 Median = 37.3	p = 0.87
Race				p = 0.22
	Non-Hispanic, White	166 (83.8%)	18 (66.7%)
	Non-Hispanic, Black	18 (9.1%)	5 (18.5%)
	Hispanic and Other	14 (7.1%)	4 (14.8%)
Marital Status (n = 52)				p = 0.11
	Married	12 (27.9%)	5 (55.6%)
	Other	31 (72.1%)	4 (44.4%)
County Type*				p = 0.33
	Small Metropolitan	136 (68.7%)	16 (59.3%)
	Other Area	62 (31.3%)	11 (40.7%)
Transmission category				p<0.0001
	MSM	135 (68.2%)	0 (0.0%)
	IDU	18 (9.1%)	6 (22.2%)
	Undetermined	16 (8.1%)	8 (29.6%)
	MSM & IDU	15 (7.6%)	0 (0.0%)
	Other	14 (7.1%)	13 (48.1%)
Healthcare Facility				p = 0.47
	Clinic	90 (45.5%)	9 (33.3%)
	Hospital	61 (30.8%)	14 (51.9%)
	Private Physician, HMO, Other	47 (23.7%)	4 (14.8%)
OIs Other Than Neuro-AIDS**				p = 0.52
	None	128 (64.6%)	22 (81.5%)
	One or More	70 (35.4%)	5 (18.5%)
Neuro-AIDS Condition				p = 0.91
	Cryptococcosis	60 (30.3%)	8 (29.6%)
	Toxoplasmosis	28 (14.1%)	5 (18.5%)
	HAD	69 (34.9%)	10 (37.0%)
	Mixed/PML/ PCNSL	41 (20.7%)	4 (14.8%)
ART Use		73 (36.9%)	10 (37.0%)	p = 0.99
Pre-HAART Era +		133 (67.2%)	11 (40.7%)	p = 0.01
PCP Diagnosis		40 (20.0%)	10 (37.0%)	p = 0.049
PCP Prophylaxis		73 (36.9%)	10 (37.0%)	p = 0.99
Deaths		152 (76.8%)	21 (77.8%)	p = 0.91

SD = Standard deviation.

*County at AIDS diagnosis with county type derived from urban influence codes.

MSM = Male sexual contact with male, IDU = Injection drug use, “Other” includes adult heterosexual contact; HMO = Health maintenance organization; OIs = Opportunistic infections.

**Excludes Pneumocystis pneumonia (PCP).

⁺Diagnosis prior to 1996.